Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-544-5 | CAS number: 584-84-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 983
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: Open epicutaneous test of Klecak 1977
- Principles of method if other than guideline:
- Method: other: Open epicutaneous test of Klecak 1977
- GLP compliance:
- not specified
- Type of study:
- open epicutaneous test
- Justification for non-LLNA method:
- A reliable guinea pig test is available from a time before the LLNA-OECD-TG was adopted. The information is sufficient to evaluate the sensitising potential of the test substance. Hence, a LLNA was not conducted.
Test material
- Reference substance name:
- 4-methyl-m-phenylene diisocyanate
- EC Number:
- 209-544-5
- EC Name:
- 4-methyl-m-phenylene diisocyanate
- Cas Number:
- 584-84-9
- Molecular formula:
- C9H6N2O2
- IUPAC Name:
- 2,4-diisocyanato-1-methylbenzene
- Details on test material:
- - Name of test material (as cited in study report): 2,4-TDI (CAS No.584-84-9). 97% minimum
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- not specified
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- other: n-butyl ether
- Concentration / amount:
- 0, 0.025, 0.5, 0.1, 0.2, 0.4 % TDI
Challengeopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- other: n-butyl ether
- Concentration / amount:
- 0, 0.025, 0.5, 0.1, 0.2, 0.4 % TDI
- No. of animals per dose:
- 5-8 young adults
- Details on study design:
- Hair on dorsum clipped 24 h before test.
Induction by two epicutaneous applications of 25 ul TDI at 8, 20 or 40%.
Five days later, challenge by 25 ul of 0, 0.025, 0.5, 0.1, 0.2, 0.4 % TDI
Additionally at lower doses, induction by two epicutaneous applications of 25 ul TDI at 4, or 8%.
Five days later, challenge by 25 ul of 0, 0.006, 0.012, 0.025, 0.05, 0.1 % TDI
Some animals rechallenges on day 9 after first challenge.
Results and discussion
In vivo (non-LLNA)
Results
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Clinical observations:
- Score = 1 for (very slight ) erythema.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 5.0. Total no. in groups: 5.0. Clinical observations: Score = 1 for (very slight ) erythema. .
Any other information on results incl. tables
The solvent controls did not produce any significant reactions although scored = 1 for very slight eryrthema. No oedema was recorded in controls.
Five days after the animals were induced with either 8, 20, or 40% TDI, they were challenged with the vehicle and dilute TDI solution (Table). The vehicle application did not produce any significant reactions at challenge. On the other hand, 0.025 to 0.4% TDI produced mean scores of 2.0 to 4.2 in all three TDI groups . While the sensitization reaction was overall dependent on the concentrations used at challenge and at induction, sensitisation occurred with all TDI exposures and there was no apparent threshold for elicitation at challenge (within the range tested). Fourteen days after induction, the 8, 20, and 40% groups were rechallenged and the 0% group was challenged (Table). Control animals did not respond with dermal hypersensitivity reactions when challenged with applications of n-butyl ether or TDI. For the TDI-induction groups, 100% of the animals had dermal reactions when challenged with 0.1 to 0.4% TDI. An apparent dose response was evident with respect to both induction and challenge concentrations: however, the response was more dependent on the challenge application.
Dermal sensitization of animals induced with 2,4-Toluene diisocyanate (TDI)
Inductions
application Challenge concentration (%)
concentration
(%) 0.0 0.025 0.05 0.1 0.2 0.4
Mean scores 24 hr after Day 5 challenge
8 0.0 2.4 2.0 2.8 2.8 3.4
20 0.0 2.0 1.6 2.8 3.2 3.4
40 0.0 2.4 2.0 3.4 4.0 4.2
Mean scores 24 hr after Day 14 challenge
0 0.0 0.5 0.9 0.6 0.0 0.4
8 0.0 1.6 1.8 2.4 3.6 3.2
20 0.0 1.6 2.0 2.8 4.6 4.2
40 0.0 2.0 2.2 2.6 4.2 4.0
The five guinea pigs (Camm Breeding Labs) which received induction application of either 0, 8, 20 or 40% TDI were challenged with 25 µl of TDI.
Maximum score in this system is 8.0.
When the 4 and 8% TDI groups were challenged with n-butyl ether, no animals showed skin reactions indicative of sensitization. In the 4.0% group, increased skin reactions, indicative of sensitization, were seen at TDI concentrations of 0.025, 0.05, and 0.1%, where three to five animals had individual positive skin reactions consistent with sensitization. Since the 0.006 and 0.012 challenge concentrations did not elicit a dermal sensitization response, these levels are apparently below the threshold for elicitation. For the 8% induction group, all challenge levels elicited some degree of sensitization. Seven of eight guinea pigs exhibited positive skin scores at 0.025% TDI, and the higher challenge levels elicited dermal hypersensitivity in all guinea pigs. It should be mentioned, however, that only one individual in the 8% test concentration responded with a skin reaction when challenged with 0.006 and 0.012% TDI. In addition, the results in the 4 ad 8% groups demonstrated that the sensitization reaction was overall dependent with respect to concentrations used at challenge and at induction.
Dermal sensitization of animals induced with 2,4-Toluene diisocyanate (TDI)
Inductions
application Challenge concentration (%)
concentration
(%) 0.0 0.006 0.012 0.025 0.05 0.1
Mean scores 24 hr after Day 5 challenge
4.0 1.0 1.0 0.9 1.6 1.4 1.6
8.0 1.0 1.1 1.1 2.1 2.4 3.3
The eight guinea pigs (Hilltop Lab Animals) which received induction doses of either 4 or 8% TDI were challenged with 25 µl of TDI.
Maximum score in this system is 8.0.
Besides demonstrating that the sensitization response was dependent on the concentrations used at challenge and induction, the second group of experiments demonstrated no observed effect levels for elicitation at challenge. When animals were induced with 4% TDI, the 0.006 and 0.012% TDI challenge levels did not elicit dermal sensitization. One extremely sensitive animal proved an exception in the 8% TDI group.
In conclusion, the results demonstrated that TDI produced sensitization at dilute induction applications and that the severity of the dermal response was dependent on the concentration administered at both induction and challenge. Related to these graded responses, no observed effect levels at challenge were determined below which the challenge concentration did not elicit a dermal hypersensitivity reaction. For the 4% TDI induction group, the no observed effect was seen with a dermal challenge application of 3µg, and a minimum effect was seen with 6.25 µg.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- .
The study demonstrated that dilute concentrations of TDI can induce sensitization in guinea pigs in a dose-dependent fashion and that challenge
reactions could be measured in a dose-responsive manner.
Classification: sensitizing
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.